Eli Lilly Inks $2.25B AI Genetics Research Pact With Profluent
By Al Barbarino · April 28, 2026, 2:45 PM EDT
AI-focused biotech Profluent said Tuesday it has entered a multiprogram, strategic research collaboration with Eli Lilly and Co. to treat diseases with high unmet need, in a deal that involves an...
To view the full article, register now.